bit.bio

Synthetic biology for human health

Cambridge, United Kingdom · Founded 2016 · $224.5M raised

Headquarters
Cambridge
Employees
51–200
Founded
2016
Business Model
B2B
Website
bit.bio
Total Funding
$224.5M
Last Round
$50.0M Series CJan 2026
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds for this company. The full record is or through the API.

About

bit.bio manufactures induced-pluripotent-stem-cell-derived human cells for drug discovery, disease modeling, and cell-therapy research. Founded in 2016 as a University of Cambridge spinout, the company is headquartered in Cambridge, UK. Its core technology, opti-ox, is a precision gene-targeting method for reprogramming stem cells into specific human cell types with high purity and batch consistency; branded product lines include ioCells (research-grade neurons, immune cells, and hepatocytes), the ioScreen CRISPR screening service, and the txCells cell-therapy pipeline. bit.bio has raised approximately $225 million from investors including ARCH Venture Partners, Charles River Laboratories, Foresite Capital, National Resilience, and Tencent, and employs between 51 and 200 people.

Summary

bit.bio is a Biotech company based in Cambridge, United Kingdom, founded in 2016. It has raised $224.5M in total across 4 rounds, most recently a $50.0M Series C round in Jan 2026.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CJan 2026
$50.0M

Sign up to see all 4 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

bit.bio on Indexed.vc
<a href="https://indexed.vc/companies/bit-bio"><img src="https://indexed.vc/api/badge/company/bit-bio" alt="bit.bio on Indexed.vc" width="260" height="76" /></a>